CYCLOSPORIN A
T-Cell Non-Hodgkin Lymphoma
Robert Lowskyprotein_peptidePhase 2Dormant
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 89/ 100
Competitive context
7 Active assets in the T-Cell Non-Hodgkin Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fludarabine Beijing GoBroad Hospital | Phase 3 | BB |
Anti-Thymoglobulin, Rabbit Stanford University | Phase 2 | BB |
FILGRASTIM Dana-Farber Cancer Institute | Phase 2 | B |
Allogeneic Cluster Of Differentiation 8 + Memory T-Cells Robert Lowsky | Phase 2 | B |
CENTRAL MEMORY T-CELLS (AUTOLOGOUS) Robert Lowsky | Phase 2 | B |
View all 14 →
Same molecule, other indications
CYCLOSPORIN A is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →